Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01690663 · ClinicalTrials.gov registry record · NA

Dose Response Study of Dexamethasone in Combination With Bupivacaine 0.25%

A NA study of Post-surgical Pain, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
89
Enrollment target
1
Study location

NCT01690663 is a NA study of Post-surgical Pain that has completed, run by University of Pennsylvania. The registered enrollment target is 89 participants, below the 306-participant average among 4 other Post-surgical Pain trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01690663, a NA study of Post-surgical Pain, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
89 participants
Enrollment target
1
Study location

Study Summary

When used in conjunction with a local anesthetic, dexamethasone may prolong both the sensory and motor effects of high supraclavicular brachial plexus nerve block (SBP) in arthroscopic shoulder surgery. This study seeks to determine if there is a relationship between the duration of sensory and motor blockade in supraclavicular brachial plexus nerve blocks (SBP) when combined with increasing doses of dexamethasone.

Conditions Studied

Interventions

  • DRUG Dexamethasone
  • DRUG normal saline
  • DRUG Bupivacaine 0.25%

Study Locations (1)

Pennsylvania

  • Penn Presbyterian Medical Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2012-09
Est. Completion 2015-02
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT01690663

The ClinicalTrials.gov registry entry for NCT01690663 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 306-participant average among 4 other Post-surgical Pain trials with a reported enrollment target (71% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post-surgical Pain appearing as the primary indexed condition, and to 3 interventions - of which Dexamethasone is the first listed.

NCT01690663 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01690663 about?

NCT01690663 is a clinical study titled "Dose Response Study of Dexamethasone in Combination With Bupivacaine 0.25%". When used in conjunction with a local anesthetic, dexamethasone may prolong both the sensory and motor effects of high supraclavicular brachial plexus nerve block (SBP) in arthroscopic shoulder surgery. This study seeks to determine if there is a relationship between the duration of sensory and moto...

What is the current status of trial NCT01690663?

This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2012-09. Estimated completion is 2015-02.

What conditions does trial NCT01690663 study?

This clinical trial studies the following conditions: Post-surgical Pain.

What interventions are being tested in trial NCT01690663?

The interventions under investigation include: Dexamethasone (DRUG), normal saline (DRUG), Bupivacaine 0.25% (DRUG).

Who is sponsoring clinical trial NCT01690663?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01690663 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post-surgical Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.